Skip to content
Trial Eligibility
Menu

Healthy Volunteers Study

NCT06962059

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to examine the role of the bacterial environments and metabolites in the early detection and prediction of ovarian cancer development. Vaginal swabs and stool samples will be collected from healthy volunteers, or those without a known ovarian cancer diagnosis or genetic ovarian cancer risk. These samples will be compared to samples from participants with increased cancer risk and ovarian cancer diagnoses.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Ovarian Cancer
  • Genetic Predisposition to Disease

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
30 to 50 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
Abramson Cancer Center at Penn Medicine
Last updated on ClinicalTrials.gov
February 5, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.